Table 1.
Patient characteristics
| 65 patients | |
|---|---|
| Sex, male, n (%) | 46 (71) |
| Age, years (±SD) | 60 ± 8 |
| AF type, paroxysmal, n (%) | 30 (46) |
| AF duration, years [IQ] | 4 [1–35] |
| BMI, kg/m2 (±SD) | 27 ± 4 |
| BSA, m2 (±SD) | 2.1 ± 0.2 |
| NT-proBNP, pmol/l [IQ] | 276 [50–3135] |
| Hypertension, n (%) | 23 (35) |
| Diabetes Mellitus, n (%) | 2 (3) |
| History myocardial infarction, n (%) | 4 (6) |
| History PCI, n (%) | 5 (8) |
| History congestive heart failure, n (%) | 10 (15) |
| History PVI, n (%) | 13 (20) |
| History of stroke, n (%) | 5 (8) |
| Medication | |
| ß-blocker, n (%) | 36 (54) |
| RAAS inhibition, n (%) | 18 (28) |
| Digoxine, n (%) | 9 (14) |
Abbreviations: AF atrial fibrillation, BMI body mass index, BSA body surface area, IQ interquartiles, PCI percutaneous coronary intervention, PVI pulmonary vein isolation, RAAS renine angiotensin aldosterone system